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Background: Dengue shock syndrome (DSS), a severe life-threatening form of dengue infection, mostly occurs in
children. A recent genome wide association study (GWAS) identified two SNPs, rs3132468 of major histocompatibility
complex class I polypeptide-related sequence B (MICB) and rs3765524 of phospholipase C, epsilon 1 (PLCE1), associated
with DSS in Vietnamese children. In this study, to examine whether an identical association is found in a different
population, the association of these two SNPs with DSS was assessed in Thai children with dengue.
Methods: The rs3132468 and rs3765524 SNPs were genotyped in 917 Thai children with dengue: 76 patients with
DSS and 841 patients with non-DSS. The allele frequencies were compared between DSS and non-DSS groups by
one-sided Fisher’s exact test. The association of rs3132468 and rs3765524 with the mRNA expression levels of MICB
and PLCE1 were assessed in EBV-transformed lymphoblastoid cell lines.
Results: The reported DSS-risk alleles were significantly associated with DSS in Thai patients with dengue (one-sided
P = 0.0213 and odds ratio [OR] = 1.58 for rs3132468-C and one-sided P = 0.0252 and OR = 1.49 for rs3765524-C).
The rs3132468-C allele showed a significant association with lower mRNA level of MICB (P = 0.0267), whereas the
rs3765524-C allele did not. These results imply that the MICB molecule may play an important role in the prevention
of DSS in dengue infection.
Conclusions: Together with previous association studies, we conclude that rs3132468-C at MICB and rs3765524-C
at PLCE1 confer risk of DSS in Southeast Asians.
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Dengue is a mosquito-borne disease caused by the den-
gue virus, a small single-stranded RNA virus comprising
four distinct serotypes. Approximately two fifths of the
world’s populations (2.5 billion people) are at risk of
dengue, and Southeast Asia is one of the most seriously
affected regions. The most severe form of dengue is den-
gue shock syndrome (DSS), a leading cause of death
resulting from dengue infection [1].
The clinical outcome of DSS is affected by a number of
factors [2,3]. Over the last decade, great efforts have been
made to elucidate host genetic factors (i.e., polymorphisms)* Correspondence: juno-tky@umin.ac.jp
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unless otherwise stated.that are involved in the severity of dengue [4,5]. Recently, a
genome wide association study (GWAS) identified two
loci, MHC class I polypeptide-related sequence B (MICB)
and phospholipase C, epsilon 1 (PLCE1), associated with
DSS in Vietnamese population [6]. Although GWAS pro-
vides strong evidence of association, replication studies in
different populations or ethnic groups are required to
examine whether the same association is commonly found
in human populations regardless of the difference in envir-
onmental and genetic factors. Furthermore, in the case of
infectious diseases, such as dengue, differences in the gen-
etic background of infectious organisms may cause
population-specific association. In the present study, in
Thai patients with dengue, we investigated the associationtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ously found in Vietnamese patients [6].
Methods
Subjects
A total of 917 patients with dengue, treated at Ratcha-
buri Hospital and Lampang Hospital, Thailand during
1999 to 2004, were examined in this study. All patients
were ≤15 years old at diagnosis. The dengue virus infec-
tion was confirmed in these patients by dengue IgM/IgG
capture ELISA, RT-PCR, and/or dengue virus isolation
at the Arbovirus Laboratory, National Institute of
Health, Department of Medical Sciences, Ministry of
Public Health, Thailand. The patients were classified into
three groups: dengue fever (DF), dengue hemorrhagic
fever (DHF) and DSS according to the WHO 1997 cri-
teria [7]. DF is defined as an acute febrile stage with vari-
ous nonspecific symptoms, such as headache, retro-orbital
pain, myalgia, arthralgia, rash, hemorrhagic manifestations,
leukopenia, and joint and muscular pain. DHF is diagnosed
when the patient has additionally all the following symp-
toms: bleeding (hemorrhagic tendencies), plasma leakage
(≥20% change in hematocrit or signs of pleural effusion,
ascites, and hypoproteinemia), and thrombocytopenia
(platelet count ≤100,000/mm3). DSS, a severe form of den-
gue infection, is defined as DHF with tachycardia (>100/
min), narrow pulse pressure (≤20 mmHg), or hypotension
(systolic blood pressure <90 mmHg) with cold clammy
skin and restlessness.
This study was approved by the Institutional Review
Board for Research on Human Subjects, the Department
of Medical Science, Ministry of Public Health, Thailand;
the Institutional Review Board of the Faculty of Tropical
Medicine, Mahidol University, Thailand; and the Research
Ethics Committee of the Faculty of Medicine, University
of Tsukuba, Japan. Unlinked anonymous blood samples
were obtained from the unidentifiable leftover blood of la-
boratory diagnosis of dengue infection. According to the
guideline of Thailand [8], no specific consent forms were
required from the patients in this case, since the Ethics
Committee approved.
Genotyping
Genomic DNA was extracted from peripheral blood
leukocytes using a QIAamp Blood Kit (Qiagen, Hilden,
Germany). Two SNPs, rs3132468 at MICB and rs3765524
at PLCE1, were genotyped by TaqMan® SNP Genotyping
Assay (Applied Biosystems, Foster City, CA, USA).
mRNA expression data
Normalized mRNA data from Epstein–Barr virus-
transformed lymphoblastoid cell lines derived from 45
JPT and 45 CHB HapMap subjects were obtained from
the database of the Gene Expression Variation (GENEVAR)project (http://www.sanger.ac.uk/resources/software/genevar/)
[9,10]. The mRNA expression data detected by GI_26787987-
S probe for MICB and GI_19923454-S for PLCE1 were used
in this study. The genotype data of rs3132468 and
rs3765524 in HapMap JPT + CHB individuals were
obtained from the HapMap database [11,12].
Statistical analyses
To assess the association of rs3132468 and rs3765524 with
DSS, the genotype and allele frequencies were compared by
Fisher’s exact test between DSS and non-DSS (DF +DHF).
A logistic regression analysis adjusted for age, sex, and geo-
graphic location (i.e., hospital) was further performed to as-
sess the association of each SNP with DSS. In a logistic
regression analysis, the number of DSS-risk alleles (i.e., 0, 1,
or 2) was used as an independent variable. Because the
DSS-risk alleles (rs3132468-C and rs3765524-C) were pre-
viously identified [6], one-sided P-values were calculated.
The associations of MICB and PLCE1 SNPs with mRNA
expression levels of MICB and PLCE1 gene were evalu-
ated, respectively, using a simple regression analysis with
the number of DSS-risk allele as an independent variable.
The significance level of a statistical test was set at 0.05
(one-sided P-value <0.05 and two-sided P-value <0.05
were considered to be statistically significant in association
tests of DSS and mRNA expression level, respectively). To
search for functional SNPs being in linkage disequilibrium
(LD) with rs3132468 (r2 ≥ 0.8) in HapMap JPT and CHB
populations [11,12], an in silico tool [13] was used. ESEfin-
der (http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?
process=home) was used to assess whether SNPs are lo-
cated in exonic splicing enhancers (ESEs). ESEs are bind-
ing sites for Ser/Arg-rich proteins (SR proteins) that have
multiple functions in the pre-mRNA splicing process.
Results
Patients with dengue
A total of 917 laboratory-confirmed patients with dengue
aged ≤15 years old were investigated in this study. Patients
were recruited from Ratchaburi Province and Lampang
Province, Thailand. The patients with dengue were classi-
fied into three groups: 409 patients with DF, 432 patients
with DHF, and 76 patients with DSS, according to WHO
1997 criteria (Table 1). In this study, patients with DF and
DHF were regarded as patients with non-DSS.
Association test
The allele frequencies of rs3132468-C at MICB and
rs3765524-C at PLCE1 were compared between DSS and
non-DSS groups (Table 2). Because the significant asso-
ciations of rs3132468-C and rs3765524-C with risk for
DSS have been reported in Vietnamese children, the al-
ternative hypothesis here should be that the allele fre-
quencies of rs3132468-C at MICB and rs3765524-C at
Table 1 Subjects investigated in this study
Characteristics Dengue patients
DF (n = 409) DHF (n = 432) DSS (n = 76)
Age (years)a 9 (1, 15) 10 (0, 15) 9 (3, 15)
Sex:
Male 213 235 41
Female 196 197 35
Region:
Ratchaburi 137 322 52
Lampang 172 110 24
Serotype:
DEN-1 153 136 15
DEN-2 109 158 39
DEN-3 92 73 6
DEN-4 54 64 16
DEN-3 + DEN-4 0 1 0
aMedian (minimum, maximum).
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with patients with non-DSS. In other words, the one-
sided test should be conducted to confirm the previous
finding. The one-sided Fisher’s exact test showed that
both reported DSS-risk alleles were associated with risk
for DSS in Thai children (one-sided P = 0.0213 and per
allele odds ratio [OR] = 1.58 for rs3132468-C; one-sided
P = 0.0252 and per allele OR = 1.49 for rs3765524-C).
To consider the effects of age, sex, and hospital (i.e., geo-
graphic location of subjects) on the association, a logistic
regression analysis adjusted for these independent vari-
ables was further performed. The logistic regression ana-
lysis confirmed the significant association of rs3132468-C
at MICB and rs3765524-C at PLCE1 with DSS in Thai
patients with dengue (one-sided P = 0.0154, per allele
OR =1.57, two-sided 95% CI: 1.11–2.22 for rs3132468-C;
one-sided P = 0.0226, OR = 1.48, two-sided 95% CI: 1.07–
2.04 for rs3765524-C). The independent variables, age,
sex, and geographic location, showed no significant associ-
ation with DSS. The results from logistic regression ana-
lysis were consistent with those from the Fisher’s exact
test.
Association of DSS-risk allele with mRNA expression level
To examine the functional significance of rs3132468 at
MICB and rs3765524 at PLCE1, the association betweenTable 2 Allelic association test for MICB rs3132468 and PLCE1
Allele (gene) Dengue patients
DSS non-DSS
rs3132468-C (MICB) 0.217 0.149
rs3765524-C (PLCE1) 0.763 0.684
P-value was calculated by using Fisher’s exact test.the DSS-risk allele and the mRNA expression level was
evaluated. The mRNA expression levels of MICB and
PLCE1 in EBV-transformed lymphoblastoid cell lines from
the HapMap JPT and CHB subjects are shown in Figure 1.
The copy number of rs3132468-C in an individual (i.e., 0,
1, or 2) was inversely associated with the level of mRNA
expression of MICB (P = 0.0267 and partial regression co-
efficient = −0.126), whereas no significant association was
observed between rs3765524-C and mRNA level of PLCE1
(P = 0.0863 and partial regression coefficient = 0.0209).
In silico analysis
The rs3132468 SNP is located in intron 6 of MICB. Al-
though rs3132468 was statistically associated with risk
for DSS, a SNP primarily associated with DSS may not
be rs3132468. Therefore, we used an in silico tool [13]
to search for functional SNPs being in LD with
rs3132468. Seventeen SNPs were discovered to be in LD
(r2 ≥ 0.8) with rs3132468 in HapMap JPT population
(data not shown). One of these 17, rs3828916, in exon 2
of MICB, was predicted by ESEfinder (http://exon.cshl.
edu/ESE/) to be located in ESEs that are binding sites
for SR proteins, SF2/ASF and SRp40. Because both al-
leles (i.e., rs3828916-C and rs3828916-G) demonstrated
scores larger than the default threshold values (i.e., 1.956
for SF2/ASF and 2.670 for SRp40), it is unclear whether
rs3828916 has functional significance. At the PLCE1
locus, a total of 28 SNPs were in LD (r2 ≥ 0.8) with
rs3765524 in HapMap JPT + CHB populations. Of these
28 SNPs, rs753724, rs2274223, and rs11187870 were
predicted to have a functional significance in the in silico
analysis using the SNPinfo Web Server [13]. The rs753724
SNP located in the upstream region of PLCE1 was pre-
dicted to be located in the transcription factor binding
sites. The rs2274223 is a nonsynonymous SNP, which may
affect the PLCE1 protein function through amino acid al-
teration. The rs11187870 SNP was predicted to be located
in microRNA-binding sites. Since the above mentioned
SNPs may be primary ones with functional significance,
we should not conclude that MICB rs3132468 and PLCE1
rs3765524 are causative SNPs associated with DSS.
Discussion
The present study revealed that MICB and PLCE1 SNPs
are associated with a progression from less severe symp-
tom of dengue to DSS in Thai children with dengue.rs3765524

















































Figure 1 mRNA expression level and SNP genotype. (a) mRNA expression level of MICB in each genotype of rs3132468. The rs3132468–C
allele was associated with lower mRNA expression level of MICB (P = 0.0267 and partial regression coefficient = −0.126). (b) mRNA expression level
of PLCE1 in each genotype of rs3765524. The rs3765524–C allele was not associated with mRNA expression level of PLCE1 (P = 0.0863 and partial
regression coefficient = 0.0209). A regression line is represented by a dashed line. The number of samples for each genotype is presented
in parentheses.
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esis of DSS remain to be elucidated. MICB is one of
stress-induced molecules expressed by virus-infected
cells. This molecule interacts with and activates the nat-
ural killer group 2 member D (NKG2D) receptor on NK
cells. The activated NK cells induce the killing of the
virus-infected cells. Our study showed that a DSS-risk
allele, rs3132468-C of MICB, was significantly associated
with lower mRNA expression of MICB. As suggested by
Whitehorn et al. [14], dengue virus-infected cells with
lower MICB expression are plausible to escape from the
NKG2D-mediated killing by NK cells. Infected cells es-
caping the host immune response may mediate the
pathogenesis of DSS because high dengue viremia titer
is associated with increased disease severity [15]. This
requires to be studied in future by the evaluation of the
expression levels of MICB and the viremia titer in pa-
tients with dengue.
In this study, non-DSS group, compared with DSS group,
consisted of patients with DF and DHF. When patients
with DSS were compared only with patients with DF, the
allele frequencies of rs3132468-C at MICB and rs3765524-
C at PLCE1were significantly higher in DSS group than in
DF group (one-sided P = 0.0119 for rs3132468 at MICB
and one-sided P = 0.0223 for rs3765524 at PLCE1). When
patients with DSS were compared only with patients with
DHF, the difference in allele frequency of rs3765524-C at
PLCE1 between DSS and DHF groups was statistically
significant (one-sided P = 0.0399), and the difference in
allele frequency of rs3132468-C at MICB was marginally
significant (one-sided P = 0.0521). In contrast, no sig-
nificant difference in allele frequencies of rs3132468-C
and rs3765524-C was observed between DHF and DF
groupss (one-sided P = 0.1454 for rs3132468 at MICB
and one-sided P = 0.3155 for rs3765524 at PLCE1).
These results suggest that rs3132468-C and rs3765524-Care not associated with risk for DHF except for DSS in
Thai dengue patients.
Previous association studies using cord blood controls
suggest that MICB and PLCE1 SNPs are associated with
not only DSS [6] but also less severe form of dengue
[14]. Our study design allows us to exclude the con-
founding factors involved in infection with dengue virus
and symptomatic dengue infection. However, the limita-
tion is that the possible association of MICB and PLCE1
SNPs with susceptibility to less severe form of dengue
cannot be assessed, since only patients with symptomatic
dengue infection are available. To examine this possibil-
ity in Thai dengue patients, patients with asymptomatic
dengue infection remain to be investigated.
Conclusions
The present study in Thai patients with dengue success-
fully replicated the associations of MICB and PLCE1
SNPs with DSS that were reported by GWAS in Viet-
namese patients [6]. Thus, we conclude that rs3132468-
C at MICB and rs3765524-C at PLCE1 are risk factors of
DSS in Southeast Asians.
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